Business Context and Reporting Period
Company: Daré Bioscience, Inc. (DARE)
Filing Type: Form 8-K (Current Report)
Date of Report: October 21, 2024
Event: Entry into a Material Definitive Agreement (Equity Line of Credit) with Lincoln Park Capital Fund, LLC.
Key Financial Metrics and Transaction Details
This filing does not report standard operating financial metrics (revenue, profit, cash flow) as it is a current report regarding a financing agreement. Key transaction metrics include:
- Total Commitment: Up to $15.0 million in common stock purchases by Lincoln Park.
- Initial Issuance: 137,614 shares issued immediately as consideration for the commitment.
- Outstanding Shares (Pre-Transaction): 8,555,864 shares.
- Exchange Cap: Limited to 19.99% of pre-transaction outstanding shares (1,711,172 shares) unless specific price thresholds are met or shareholder approval is obtained.
- Maximum Single Purchase: $500,000 per Regular Purchase.
- Term: 24 months from the Commencement Date (expected after SEC registration effectiveness).
Material Changes and Pricing Mechanics
The company entered into a Purchase Agreement allowing it to sell shares at its discretion. Pricing for "Regular Purchases" is determined as the lower of:
- The lowest sale price on the business day of initiation.
- The average of the three lowest closing sale prices during the 10-business day period preceding initiation.
Volume Limits: Regular purchases are capped at 30,000 shares, increasing to 35,000 or 40,000 shares if the closing price is not below $5.00 or $7.50, respectively. Lincoln Park is prohibited from beneficially owning more than 4.99% of outstanding shares.
Guidance, Outlook, and Risks
Use of Proceeds: Expected to be used for working capital and general corporate purposes. Proceeds are contingent on market conditions and the company's election to sell shares.
Management Commentary: The company retains the right to terminate the agreement at any time after the Commencement Date without penalty. Lincoln Park has no right to require sales.
Risks and Contingencies:
- Registration Requirement: Sales cannot commence until an SEC registration statement is declared effective (filed by December 5, 2024).
- Nasdaq Rules: Issuances are subject to the 19.99% Exchange Cap unless the average sale price equals or exceeds $3.59 per share.
- Suspension Events: Sales may be suspended during specific events defined in the agreement.
- Forward-Looking Statements: Actual proceeds and timing depend on market volatility and the company's funding decisions.
Investor Verification Checklist
- Verify the effectiveness date of the SEC registration statement required to commence sales.
- Monitor the 4.99% beneficial ownership limit for Lincoln Park to understand potential sales pauses.
- Track the average sale price to determine if the $3.59 threshold is met to bypass the 19.99% Exchange Cap.
- Review the full text of the Purchase Agreement (Exhibit 10.1) for specific definitions of "Suspension Events."
- Confirm the number of shares issued as the initial commitment fee (137,614 shares) and its impact on immediate dilution.